About IDDI
We are an expert clinical data science , regulatory statistics and high-level strategic consulting contract research organization (CRO), providing agile clinical trials services for pharmaceutical, biotech, and medical device/diagnostic companies.
With a proven track record, IDDI provides expert Biostatistics and Clinical Data Science Services to ensure the successful execution of your clinical development program.
Passion. Science. Experience.
A passionate and experienced science-led team, committed to delivering submission-ready clinical data.
At IDDI our focus is on our people; our passion is advancing innovative biomedical research.
Meet Our Team
Commitment to Quality and Precision
“IDDI was of great benefit, particularly with respect to their responsiveness, their commitment to quality and precision, and their ability to meet our very ambitious timelines.”
Jim Taylor, CEO Oraya Therapeutics, Newark, CA, USA
How IDDI Adds Value to Your Clinical Data
Strategic-level consultancy to optimize your clinical development program even in clinical trials with complex settings.
Delivered by talented, forward-thinking and science-led professionals, who will take ownership of your needs.
Over 30 years in business ensuring continuity in your clinical development.
IDDI’s culture is scientifically driven, thanks to its founder and Chief Scientific Officer, Marc Buyse, ScD.
Expert clinical data services (EDC/RTSM/Medical Coding) providing flexible solutions for collection, standardization, analysis, documentation and reporting of your clinical data.
A Project Manager is assigned to every project. Flexibility, responsiveness, proactiveness are skills often mentioned by our customers.
Experienced contract research organization with a solid understanding of the clinical development process and breadth of therapeutic areas expertise.
Thanks to a strong collaborative approach with Academics and Key Opinion Leaders.
Resource Library
Discover our on-demand recorded webinars, podcasts, videos and scientific articles.
Videos ›
Webinars ›
Podcasts ›
Scientific Articles ›
Brochures ›
Fast growing company – Rewarding career. Join us and contribute to the progress of clinical research. An inspiring and exciting career with international and challenging projects is waiting for you!
Join UsMay 16, 2023
GPC – A novel statistical method for outcome analysis and reporting of prioritized composite endpoints
Join IDDI webinar to learn how the GPC method can be used to design clinical trials with multiple endpoints. You…
View WebinarIDDI exhibiting at Clinical Trial in Oncology CTO East Coast 2024
Meet the IDDI experts at the 13th Annual Clinical Trial in Oncology (CTO) East Coast 2024 – Stop by Booth…
Podcast Series: Accelerated Approvals – EMA’s conditional approval pathway
In Episode 6 of the IDDI Podcast Series, our experts discuss the corresponding pathways in Europe (EMA’s conditional approval pathway)…
IDDI at CNS Therapeutics Xchange 2024
IDDI team is excited to attend CNS Therapeutics Xchange 2024 and present a poster about new FDA guidance on DMCs!…
Podcast Series: Accelerated Approvals – Role of AA in Non-oncology Trials
Episode 5 of the IDDI Podcast Series: Accelerated Approvals shed light on the role of AA in non-oncology trials with…
IDDI at WNAR 2024
Join IDDI’s Senior Scientist, Statistical Consulting – Vincent Staggs, PhD as he’s chairing a session at WNAR 2024! IDDI team…
Podcast Series: Accelerated Approvals – Role of Endpoints
Tune in to Episode 4 of IDDI Podcast Series Accelerated Approvals to explore the significant role of Endpoints in securing…
IDDI at PSI 2024
IDDI presenting a poster on “Randomization tests in R” at the upcoming PSI 2024 In a combined effort, Emmanuel Quinaux…
Podcast Series: Accelerated Approvals – Role of Randomization
The third episode of the IDDI Podcast Series: Accelerated Approvals delves deeper into the fact that FDA has explicitly stated…
IDDI exhibiting at DIA 2024 Global Annual Meeting
Meet IDDI team at Drug Information Associate DIA 2024 Global Annual Meeting – Visit our booth #1400! Schedule a meeting…
Podcast Series: Accelerated Approvals – One vs two trials approach strategies
Listen to the second episode of our Podcast Series as our experts dive deep into one vs two trials approaches…